Needham & Company Reiterates a 'Buy' on Dendreon (DNDN); Clear Messages Emerged That On-Label PROVENGE Use Consistent with Survival Benefit
Tweet Send to a Friend
Needham & Company reiterates a 'Buy' on Dendreon (NASDAQ: DNDN), PT $62.
Needham analyst says, "Yesterday we spent the day ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham analyst says, "Yesterday we spent the day ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
